Double attack on lingering lung cancer cells after surgery
NCT ID NCT07353476
Summary
This study is for people with advanced lung cancer who had chemotherapy and immunotherapy before surgery, but cancer cells were still found in their lymph nodes after the operation. It tests whether adding a targeted radiation treatment to the standard immunotherapy drug helps keep the cancer from coming back better than the drug alone. Researchers want to see if this combination gives patients more time cancer-free.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.